PT  - JOURNAL ARTICLE
AU  - Haissan Iftikhar
AU  - Muhammad Sohail Awan
AU  - Shayan Khalid Ghaloo
AU  - Saira Fatima
TI  - Sclerosing mucoepidermoid carcinoma with eosinophilia of thyroid
AID  - 10.1136/bcr-2018-225685
DP  - 2019 Aug 01
TA  - BMJ Case Reports
PG  - e225685
VI  - 12
IP  - 8
4099  - http://casereports.bmj.com/content/12/8/e225685.short
4100  - http://casereports.bmj.com/content/12/8/e225685.full
SO  - BMJ Case Reports2019 Aug 01; 12
AB  - Sclerosing mucoepidermoid carcinoma of the thyroid was first reported in 1991. This tumour type may develop as associated to Hashimoto thyroiditis. There are two variants of mucoepidermoid carcinoma of thyroid. The conventional and the sclerosing variants. Sclerosing mucoepidermoid carcinoma with eosinophilia of thyroid (SCME) has recently been recognised as a separate disease entity by the WHO. We report a case of SCME in a 62-year-old male patient who presented with a painless anterior neck swelling. Total thyroidectomy was performed, and no adjuvant treatment administered. The patient remained disease free up until 10 months of follow-up. Approximately 40 cases are reported in literature. We report the second case of SCME in Asian men. Sclerosing mucoepidermoid carcinoma with eosinophilia of thyroid should be differentiated from the conventional mucoepidermoid carcinoma. Patients should also be advised of long-term follow-up for surveillance.